Page last updated: 2024-08-24

3-iodobenzylguanidine and Depressive Disorder, Major

3-iodobenzylguanidine has been researched along with Depressive Disorder, Major in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaneko, K; Matsumura, H; Nakagome, K; Ohta, Y; Pu, S; Terachi, S; Yamada, T; Yamanashi, T; Yokoyama, K1
Arai, T; Asada, T; Darby, D; Hattori, S; Kikuchi, N; Mizukami, K; Ogawa, R; Takahashi, S1

Other Studies

2 other study(ies) available for 3-iodobenzylguanidine and Depressive Disorder, Major

ArticleYear
Milnacipran influences the indexes of I-metaiodobenzylguanidine scintigraphy in elderly depressed patients.
    Psychiatry and clinical neurosciences, 2014, Volume: 68, Issue:3

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Antidepressive Agents; Brain; Cyclopropanes; Depressive Disorder, Major; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Milnacipran; Radionuclide Imaging; Radiopharmaceuticals

2014
Ventilatory Response to Hypercapnia Predicts Dementia with Lewy Bodies in Late-Onset Major Depressive Disorder.
    Journal of Alzheimer's disease : JAD, 2016, Volume: 50, Issue:3

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Depressive Disorder, Major; Follow-Up Studies; Heart Rate; Humans; Hypercapnia; Hypotension, Orthostatic; Kaplan-Meier Estimate; Lewy Body Disease; Middle Aged; Partial Pressure; Psychiatric Status Rating Scales; Retrospective Studies; Ventilators, Mechanical

2016